Touraine–Solente–Golé syndrome
Touraine–Solente–Golé syndrome (TSG), also known as Pachydermoperiostosis or Primary hypertrophic osteoarthropathy, is a rare genetic disorder characterized by skin changes (pachydermia), excessive sweating (hyperhidrosis), and bone and joint abnormalities (periostosis).
Symptoms[edit | edit source]
The symptoms of Touraine–Solente–Golé syndrome typically appear during adolescence or early adulthood. The most common symptoms include pachydermia, which is thickening of the skin, and hyperhidrosis, which is excessive sweating. Other symptoms may include arthralgia, which is joint pain, and periostosis, which is new bone formation often around the distal ends of long bones.
Causes[edit | edit source]
Touraine–Solente–Golé syndrome is caused by mutations in the HPGD or SLCO2A1 genes. These genes are involved in the breakdown of certain prostaglandins, which are hormone-like substances that play a role in a wide variety of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation.
Diagnosis[edit | edit source]
Diagnosis of Touraine–Solente–Golé syndrome is based on the clinical symptoms and confirmed by genetic testing. Imaging studies such as X-ray or MRI may be used to detect bone changes.
Treatment[edit | edit source]
There is currently no cure for Touraine–Solente–Golé syndrome. Treatment is symptomatic and may include medications to manage pain and inflammation, skin care to manage the pachydermia and hyperhidrosis, and in some cases, surgery to correct bone deformities.
Epidemiology[edit | edit source]
Touraine–Solente–Golé syndrome is extremely rare, with fewer than 200 cases reported in the medical literature. It affects males more frequently than females, and has been reported in individuals of various ethnic backgrounds.
See also[edit | edit source]
NIH genetic and rare disease info[edit source]
Touraine–Solente–Golé syndrome is a rare disease.
| Touraine–Solente–Golé syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
